Lenzetto 1,53 mg po potisku, transdermalni sprej, otopina
| Name | Lenzetto 1,53 mg po potisku, transdermalni sprej, otopina |
|---|---|
| Marketing Authorisation Number | HR-H-173338597 |
| Active Substance | estradiol hemihidrat |
| Composition | jedan potisak sadrži 1,53 mg estradiola (što odgovara 1,58 mg estradiol hemihidrata) |
| Pharmaceutical Form | transdermalni sprej, otopina |
| Packaging [MA Number for Packaging] | 1 bočica sa 6,5 ml otopine, u kutiji [HR-H-173338597-01] 1 bočica sa 6,5 ml otopine u kutiji, 3 pakiranja u kutiji [HR-H-173338597-02] |
| Manufacturer | Gedeon Richter Plc., Budimpešta, Mađarska Gedeon Richter Romania S.A., Târgu Mures, Rumunjska |
| Marketing Authorisation Holder | Gedeon Richter Plc., Gyömrői út 19-21, Budimpešta, Mađarska |
| Marketing Authorisation Date | 12.03.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/164 |
| Registration Number | 381-12-01/70-21-05 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | G03CA03 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
